DGAP-News: Ahlers AG / Key word(s): Interim Report/Quarter Results Ahlers AG: Ahlers with slightly higher results and greatly improved operating cash flow in Q1 2015/16 12.04.2016 / 10:10 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- PRESS RELEASE April 12, 2016 Ahlers with slightly higher results and greatly improved operating cash flow in Q1 2015/16 - Growing core business and increasing retail revenues in a declining fashion market - Sales revenues down 2.2 percent due to discontinuation or reduction of activities of Gin Tonic and the last remaining large private label customer - Slightly higher results due to cost saving measures - Continued solid financial position and reduced net debt - Forecast for the full year remains unchanged: earnings expected to pick up notably on stable to slightly lower sales revenues due to reduced expenses Core activities grow against downward market trend in Q1 2015/16 Sales revenues of the remaining activities increased by EUR 0.4 million or 0.6 percent in the first quarter of FY 2015/16. Particularly successful were the Pioneer Authentic Jeans brand, which grew strongly by 14 percent and the ready-to-wear clothing of Pierre Cardin which generated an increase of 13 percent in sales of suits. The downward sales trend in Russia and Ukraine was halted as well. Compared to the previous year, sales revenues in these countries rose by a moderate EUR 0.6 million. Ahlers' revenues in the rest of Eastern and Central Europe increased by 6.9 percent from EUR 8.7 million to EUR 9.3 million in Q1 2015/16. The Group's own retail revenues increased by 6.5 percent in the reporting period, which represented 11.0 percent of total sales revenues (previous year: 10.2 percent). Like-for-like revenues rose by 2.4 percent in spite of difficult market conditions. The e-commerce business continued to grow positively, with sales up by 17 percent. As expected total revenues decline moderately due to discontinuation activities Total sales revenues of the Ahlers Group decreased by EUR 1.5 million from EUR 67.7 million to EUR 66.2 million in the first three months of FY 2015/16. This 2.2 percent reduction in sales revenues is exclusively attributable to the reducing Gin Tonic business (EUR -0.7 million) and the ongoing decline in sales to the last remaining private label customer (EUR -1.2 million). Cost savings through the discontinuation of Gin Tonic and other measures lead to slightly improved results EBIT before special effects at EUR 5.3 million exceeded the previous year's EUR 5.2 million by 1.9 percent. At EUR 3.52 million, consolidated net income after taxes was up by a moderate 1.7 percent on the previous year's EUR 3.46 million. Lower sales revenues and more expensive sourcing in the Far East due to currency translation effects led to a reduced gross profit margin. The minus of EUR 1.2 million or 3.4 percent was more than offset by reduced operating expenses. At EUR 28.9 million, operating expenses in Q1 2015/16 were down by EUR 1.3 million or 4.3 percent on the reporting period of the previous year (EUR 30.2 million). Much lower net working capital and reduced net debt Reduced inventories (EUR -2.1 million), lower trade receivables (EUR -3.8 million) and increased trade payables (EUR +3.5 million) helped to further streamline net working capital which decreased by a total of EUR 9.4 million (-8.6 percent). The resulting liquidity improved the operating cash flow by 26 percent or EUR 2.7 million and was used to reduce the company's financial liabilities. Net debt declined from EUR 37.7 million to EUR 33.6 million at the end of the first quarter (down EUR 4.1 million or 11 percent on the previous year). Equity ratio amounted to solid 57.1 percent on record date (previous year: 58.2 percent). Forecast confirmed: Notable increase in earnings expected Both the order situation for the spring/summer 2016 season and the good pre-orders for autumn/winter 2016 support the assumption of growing core business, which will largely offset declining sales revenues because of the discontinued or reduced activities with Gin Tonic and private label in 2016. Ahlers is confirming the forecast published in the Annual Report, according to which EBIT after special effects and consolidated net income after taxes in the fiscal year 2015/16 will clearly exceed the previous year's level through cost savings measures. Inquiries: Ahlers AG Götz Borchert Head of Marketing, Retail and Corporate Communications Phone: +49 (0)5221/ 979 270 E-mail: goetz.borchert@ahlers-ag.com --------------------------------------------------------------------------- 12.04.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Ahlers AG Elverdisser Straße 313 32052 Herford Germany Phone: +49 (0)5221 979-0 Fax: +49 (0)5221 70058 E-mail: ahlers-ag@ahlers-ag.com Internet: www.ahlers-ag.com ISIN: DE0005009708, DE0005009732 WKN: 500970, 500973 Listed: Regulated Market in Dusseldorf, Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Hamburg, Stuttgart End of News DGAP News Service --------------------------------------------------------------------------- 453375 12.04.2016
DGAP-News: Ahlers AG: Ahlers with slightly higher results
Top 10 Most Recent News Articles
SteriLance Aims for Smoother Pricks with NanoSense Move
Revamping the Lancing Game Out there in Suzhou, SteriLance Medical is steering clear of just chasing meter accuracy—do enough folks even care about glorified electronics?—they're zeroing in on the needle part of the blood glucose test, the part that pricks your finger every damn day. Yep, this new initiative is inviting blood glucose monitoring (BGM) brands to embrace...
Continue Reading
Ridgeline’s Dome Roof Award Signals Durable Craft Demand
A faceted dome in the Alabama woods is about as far from a cookie-cutter reroof as it gets. Ridgeline Roofing & Restoration’s 2026 Excellence Award from Brava Roof Tile matters because the job in Pell City demanded the sort of painstaking field execution that separates a capable contractor from a crew merely moving shingles fast. Geometry Is Where Easy Claims Go to Die...
Continue Reading
Halff Elevates People and Delivery Leadership Team
Infrastructure outfits rarely make much noise when they reshuffle leadership, but Halff’s Nov. 18 announcement deserves a closer look than the usual executive-title confetti. The employee-owned consulting firm has put Greg Carpenter in the chief people officer seat and named Leigh Hollis chief delivery officer. One role is aimed squarely at the human machinery; the...
Continue Reading
Fall Pest Risks Linger as Mild Weather Extends Threat
A cold snap is not a magic off switch for mosquitoes, ticks, or rodents, and that is the sober point behind the National Pest Management Association's fall and winter 2026 Public Health Pest Index. The group is flagging conditions, not predicting that every household in a named city will face an infestation or illness. Still, mild temperatures, rain, flooding, and plenty...
Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks
Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...
Continue Reading
Polsen Flex Deal Puts Pre-Tax Funds Behind Wearables
A pile of soon-to-expire FSA cash is a peculiar sales catalyst, but Polsen Health has found one. The Amsterdam-based preventative-health wearable company is partnering with Flex to let customers pay for every Polsen watch and strap using eligible HSA or FSA funds at checkout. No reimbursement chase, no claim forms, and buyers can split the cost with another card. For a...
Continue Reading
Microsoft-Intel Azure Pact Puts Systems Work First
Azure’s next bottleneck may be the plumbing between chips, not the chips alone. Microsoft and Intel announced on Nov. 18, 2026, a long-term expansion of their already ancient partnership aimed at shaping select pieces of Azure infrastructure for cloud and AI demand. That sounds dry, because infrastructure announcements usually do. But this one deserves a closer look: it...
Continue Reading
A €18 Million Mecca Chandelier Tests Austrian Craft
Scale Is Easy to Boast About, Delivery Is Not A 34.1-metre chandelier hanging in Mecca is the sort of job that makes ordinary project talk sound downright silly. Lights of Vienna says it designed, built, tested, shipped and installed this monster for the Grand Mosque's Shamiya area, with a contract value of roughly €18 million. That is a serious piece of work for a...
Continue Reading
Redseer's $5M Bet on Faster MENA Decision Intelligence
Speed has become the expensive commodity in Middle Eastern commerce, and Redseer is putting roughly $5 million behind the idea that executives will pay to get it. Its newly launched Benchmarks MENA 2.0 platform combines proprietary market data with strategic advisory across nine MENA markets. That sounds like another corporate dashboard pitch until you consider the target...
Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition
Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...
Continue ReadingTop 5 Most Recently Viewed Articles
Symbotic Inc. Faces Legal Challenges Amid Financial Irregularities
Symbotic Inc. Under Investigation for Securities Violations There has been a significant development for investors of Symbotic Inc. As concerns about the Company’s financial practices have arisen, the Schall Law Firm has initiated an investigation. This effort is aimed at ensuring shareholders are informed and protected amid allegations of misleading statements related...
Continue Reading
Turning Point Brands: Growth Opportunities Ahead with New Rating
Turning Point Brands Gets a Positive Buy Rating Recently, Turning Point Brands (NYSE: TPB) earned a favorable Buy rating from Roth/MKM, along with a price target set at $50. This company is known for its wide range of consumer brands in the nicotine, tobacco, and cannabis markets, particularly recognized for its popular rolling papers and moist snuff products. Growth in...
Continue Reading
NeuroSense Therapeutics Celebrates Key Manufacturing Milestone
NeuroSense Therapeutics Achieves Commercial Manufacturing Scale-Up NeuroSense Therapeutics Ltd. (NASDAQ: NRSN), a pioneering biotechnology firm dedicated to developing innovative treatments for severe neurodegenerative diseases, has announced a major milestone in its commercial journey. The company has successfully scaled up its production of PrimeC, preparing for...
Continue Reading
Discover the Potential of Azapeptides in Peptide Stability
Unveiling the Future of Peptide Stability with Azapeptide Synthesis In this informative webinar, participants will discover how strategies involving azapeptides can significantly enhance the stability of peptides and improve workflows related to synthesis. Attendees will delve into techniques for incorporating aza-amino acids within peptides that utilize traditional amino...
Continue Reading
Ascent Solar Technologies Faces Major Challenges in Market
Ascent Solar Technologies Hits 52-Week Low Ascent Solar Technologies, recognized for its cutting-edge thin-film photovoltaic modules, is currently going through a challenging period. The company's stock has reached a 52-week low of $2.32, reflecting an astonishing nearly 99.6% decline over the past year. This drastic drop underscores the significant hurdles the company...
Continue Reading